PMC7337590_01
Vaginal ultrasound showing atrophy of the uterus and ovaries.
dic-2020-3-4-g001.jpg
PMC7337590_01_dic-2020-3-4-g001.jpg
f1-dic-2020-3-4
A follow-up vaginal ultrasound showed atrophy of the uterus and ovaries (Figure 1).
PMC7337590_02
Mammography showed no increase in breast density from (A) September 2017, after 3 months' treatment with ospemifene; to (B) September 2018, after 15 month's treatment with ospemifene.
dic-2020-3-4-g002.jpg
PMC7337590_02_dic-2020-3-4-g002.jpg
f2-dic-2020-3-4
Mammography and breast ultrasound were normal (ACR breast density category B; BI-RADS score 2) (Figure 2).